SCHEMBL31522011

SCHEMBL31522011

Nc1ccc(Oc2ccc(F)c(F)c2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 2/20 0.55
NR4A1 P22736 1/20 0.54
ALDH1A1 P00352 3/20 0.48
MAP4K4 O95819 1/20 0.43
TRPA1 O75762 1/20 0.41
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863328 0.93 NR4A1 (0.61) SOS1NR4A1ALDH1A1MAP4K4CA12
SCHEMBL29394218 0.85 ALDH1A1 (0.58) SOS1NR4A1ALDH1A1CA12CA1
SCHEMBL30127396 0.83 MAOA (0.54) SOS1NR4A1ALDH1A1MEN1MITF
SCHEMBL16792619 0.83 MAOA (0.54) SOS1NR4A1ALDH1A1MEN1MITF
SCHEMBL16792533 0.83 ALDH1A1 (0.61) SOS1NR4A1ALDH1A1MAP4K4SLC1A3
SCHEMBL10704338 0.82 MEN1 (0.54) SOS1NR4A1ALDH1A1MEN1MITF
SCHEMBL18332423 0.81 AR (0.46) SOS1NR4A1ALDH1A1MAP4K4MEN1
SCHEMBL23637719 0.80 NR4A1 (0.47) SOS1NR4A1ALDH1A1MAP4K4CA12
SCHEMBL21359775 0.80 MAOB (0.60) NR4A1ALDH1A1MEN1MITFGAA
SCHEMBL29397217 0.80 NR4A1 (0.47) SOS1NR4A1ALDH1A1MAP4K4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250084056-A1 SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084056-A1 SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS CCNA1, CCNI, CCNE1 SOS1 2792/4885NR4A1 295/4885ALDH1A1 431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.